![Lee Schalop](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lee Schalop
Directeur/Membre du Conseil chez
TME PHARMA N.V.
Fortune : 98 544 $ au 31/08/2026
Profil
Lee T.
Schalop was the founder of Oncoceutics, Inc. (2009) and served as Chief Executive Officer from 2020 to 2021.
Current jobs include Director & Head-Business Development at ImmunoGenes AG, Director at The New York Chapter of the Inst of Internal Auditors, Inc., Independent Director at Lantern Pharma, Inc. starting in 2025, and Member-Supervisory Board at TME Pharma NV starting in 2024.
Former jobs include Director at Velocity Commercial Capital LLC, Director at Juvenile Diabetes Research Foundation Canada, Analyst at JPMorgan Securities LLC in 2002, Analyst at Banc of America Securities LLC in 2004, and Research Analyst at Credit Suisse First Boston Corp.
Education includes a doctorate from Albert Einstein College of Medicine, Inc., an undergraduate degree from The Wharton School of the University of Pennsylvania, and an undergraduate degree from The College of Arts & Sciences.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LANTERN PHARMA, INC. 0,38 % | 12/05/2026 | 48 544 ( 0,38 % ) | 98 544 $ | 31/08/2026 |
Postes actifs de Lee Schalop
| Sociétés | Poste | Début |
|---|---|---|
| TME PHARMA N.V. | Directeur/Membre du Conseil | 27/06/2024 |
| LANTERN PHARMA INC. | Directeur/Membre du Conseil | 28/07/2025 |
ImmunoGenes AG | Directeur/Membre du Conseil | - |
The New York Chapter of the Inst of Internal Auditors, Inc. | Directeur/Membre du Conseil | - |
Anciens postes connus de Lee Schalop
| Sociétés | Poste | Fin |
|---|---|---|
Oncoceutics, Inc.
 Oncoceutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops imipridones for cancer treatment | Directeur Général | 01/01/2021 |
Banc of America Securities LLC
 Banc of America Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 11/06/2004 |
JPMorgan Securities LLC
 JPMorgan Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 25/09/2002 |
Credit Suisse First Boston Corp.
 Credit Suisse First Boston Corp. Real Estate Investment TrustsFinance Real Estate Investment Trusts | Corporate Officer/Principal | - |
Juvenile Diabetes Research Foundation Canada
 Juvenile Diabetes Research Foundation Canada Miscellaneous Commercial ServicesCommercial Services Provides charitable fund for type 1 diabetes research | Directeur/Membre du Conseil | - |
Formation de Lee Schalop
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
36
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
JPMorgan Securities LLC
JPMorgan Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Velocity Commercial Capital LLC
 Velocity Commercial Capital LLC Real Estate Investment TrustsFinance Provides REIT, mortgage banking and financing services | Finance |
Banc of America Securities LLC
Banc of America Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Credit Suisse First Boston Corp.
Credit Suisse First Boston Corp. Real Estate Investment TrustsFinance Real Estate Investment Trusts | Finance |
Juvenile Diabetes Research Foundation Canada
Juvenile Diabetes Research Foundation Canada Miscellaneous Commercial ServicesCommercial Services Provides charitable fund for type 1 diabetes research | Commercial Services |
Albert Einstein College of Medicine, Inc.
 Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ImmunoGenes AG | |
The New York Chapter of the Inst of Internal Auditors, Inc. | |
Oncoceutics, Inc.
Oncoceutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops imipridones for cancer treatment | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The College of Arts & Sciences
 The College of Arts & Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TME Pharma NV
 TME Pharma NV BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
Lantern Pharma, Inc.
 Lantern Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer drug from advanced genomics and artificial intelligence | Health Technology |
